Mark DeLong
Corporate Officer/Principal en APELLIS PHARMACEUTICALS, INC. .
Fortuna: 2 M $ al 31/05/2024
Cargos activos de Mark DeLong
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| APELLIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/02/2018 | - |
Historial de carrera de Mark DeLong
Antiguos cargos conocidos de Mark DeLong.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | 01/01/2007 | 01/01/2018 |
Formación de Mark DeLong.
| The Pennsylvania State University | Undergraduate Degree |
| University of Michigan | Masters Business Admin |
Estadísticas
Internacional
| Estados Unidos | 5 |
Operativa
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| APELLIS PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Mark DeLong
- Experiencia
